Advanced search×

Embryo-fetal erythroid megaloblasts in the human coelomic cavity.

J Cell Physiol 225(2):385-9 (2010) PMID 20533375

The coelomic cavity is part of the extraembryonic mesoderm, surrounding amniotic cavity, embryo, and yolk sac in the early gestation. It is now believed to represent an important transfer interface and a reservoir of nutrients for the embryo. Coelocentesis by ultrasound-guided transvaginal puncture offers an easier access to the early human embryo, from 28 days post-fertilization. However, despite some studies about its biochemical composition being reported, our knowledge about the presence of cellular elements and their quality in this compartment are still limited. Here we studied human coelomic fluids sampled from 6.6 (48 days) to 10 weeks of gestation, demonstrating the presence of functional embryonic erythroid precursors, that is, megaloblasts in the coelomic cavity. The ease of access of the coelomic cavity could allow the development of novel strategies for diagnostic or therapeutic purposes by ultrasound imaging and ultrasound-guided puncture.

DOI: 10.1002/jcp.22269
Version: za2963e q8za8 q8zbc q8zc3 q8zda q8zed q8zf5 q8zgd

Similar articles you may find interesting…

  1. Potential Teratogenicity of Methimazole: Exposure of Zebrafish Embryos to Methimazole Causes Similar Developmental Anomalies to Human Methim...

    Birth Defects Res B Dev Reprod Toxicol (2013) PMID 23630110

    We studied the effects of MMI on early development by using zebrafish as a model organism. The fertilized eggs of zebrafish were collected immediately after spawning and grown in egg culture water containing MMI at various concentrations. External observation of the embryos revealed that exposure to...
  2. Clarifications on the moral status of newborns and the normative implications.

    J Med Ethics 39(5):264-5 (2013) PMID 23637424

    In this paper we clarify some issues related to our previous article 'After-birth abortion: why should the baby live?'.
  3. Metformin inhibits growth and enhances radiation response of non-small cell lung cancer (NSCLC) through ATM and AMPK.

    Br J Cancer (2013) PMID 23632475

    Metformin (2.5 μM-5 mM) inhibited proliferation and radio-sensitised NSCLC cells. Metformin (i) activated the ataxia telengiectasia-mutated (ATM)-AMPK-p53/p21(cip1) and inhibited the Akt-mammalian target of rapamycin (mTOR)-eIF4E-binding protein 1 (4EBP1) pathways, (ii) induced G1 cycle arrest a...